Average Tacrolimus Trough Level in the First Month After Transplantation May Predict Acute Rejection.

Akturka S., Erdogmus S., Kumru G., ELHAN A. H., Sengul Ş., Tuzuner A., ...Daha Fazla

Transplantation proceedings, cilt.49, sa.3, ss.430-435, 2017 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 49 Sayı: 3
  • Basım Tarihi: 2017
  • Doi Numarası: 10.1016/j.transproceed.2017.02.011
  • Dergi Adı: Transplantation proceedings
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.430-435
  • Ankara Üniversitesi Adresli: Evet

Özet

Background. Although tacrolimus is one of the essential drugs used for the prevention of rejection in kidney recipients, target trough levels are not well established. In this study, we aimed to investigate the association between average tacrolimus trough levels (TTLs) of the first month after transplantation and biopsy-proven acute rejection (BPAR) during the first 12 months after transplant.